BENGALURU (Reuters) – Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of Albuterol Sulfate Inhalation Aerosol due to a “container defect”.
(Reporting by Nishit Navin; Editing by Krishna Chandra Eluri)
US unit of India’s Cipla recalls six batches of inhaler
Jul 6, 2023 | 11:55 PM
